Repairing Lung Tissue: How Umbilical Cord Stem Cell Treatments May Heal COPD and Improve Breathing

Sorry, no results.
Please try another keyword

Understanding COPD and its Impact

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. COPD refers to lung diseases, including emphysema and chronic bronchitis, nearly always caused by long-term damage from inhaled cigarette smoke or air pollution. This triggers lasting inflammation and imbalance in lung enzymes, gradually destroying lung structures.

As COPD worsens, patients struggle with:

  • Chronic cough
  • Excess mucus
  • Wheezing
  • Progressively worsening shortness of breath

Severe flare-ups become more frequent, often requiring hospitalization for infections or inflammation. Over months to years, accelerating loss of lung function capacity is the hallmark of COPD’s increasing suffocation.

Stem Cells Have Tissue Healing Capabilities

However, stem cells are master cells naturally occurring in tissues with exceptional healing abilities.

  • Renewing themselves to multiply
  • Reducing inflammation
  • Transforming into specialized tissue cells as needed

Mesenchymal stem cells (MSCs) from bone marrow, fat, or newborn tissues like umbilical cord, secrete regenerative anti-inflammatory factors while signaling tissue repair.

Animal Studies Show Promise; Human Trials Underway

Animal studies showed lung-injected MSCs could decrease inflammation, emphysema, and mucus overproduction and restore structure and function. This paved the way for human testing.

Over a dozen trials have now studied infusing MSCs from various sources into COPD patients. Delivery methods include intravenous or airway installation, which involves directly placing cells into damaged lung passages.

These studies unanimously found stem cell administration safe with quality of life improvements. However, impacts on lung function were less consistent initially.

Repeat Cell Dosing and Lung Placement Likely Key

Two factors likely influencing results are cell doses and placement within the the lungs. Single infusion protocols may limit sustained benefits. However, emerging research utilizing concentrated, repeat MSC dosing shows measured lung function gains, indicating tissue repair.

Umbilical Cord Tissue MSCs Advantages

An excellent cell source is MSCs derived from discarded human umbilical cords, offering advantages:

  • Abundant quantities allowing higher cell doses
  • Consistent quality from single-donor tissue
  • Superior anti-inflammatory and tissue-building abilities
  • Prolonged multiplication capacity maintains cell potency
  • Extremely low risk of rejection or infection

A trial administering multiple umbilical cord MSC doses to COPD patients found over 6 months significant improvements in quality of life and fewer symptom flare-ups. Those with advanced disease had better responses.

Another recent study gave four umbilical cell infusions, which increased both quality of life and lung function measurements, suggesting treatment regenerated damaged airways and alveoli.

How MSCs May Repair Lung Tissue

MSCs facilitate lung repair through cooperative action. First, their secretion of growth-nourishing factors activates lung stem cells, maintaining normal structure and function. Second, they reduce inflammatory responses that interfere with healing. Finally, some MSCs directly replace depleted specialized cell types.

Ongoing research also seeks to identify drugs that may further stimulate patients’ innate lung regenerative systems.

Cautious Optimism

In conclusion, accumulating evidence shows quality of life improvements, reduced COPD flare-ups and early indicators of tissue repair from stem cell therapy. As techniques continue optimization, stem cell treatment offers renewed hope for restoring lung capacity beyond current limitations. Those with advancing COPD should inquire into these emerging advances at specialty centers like Stem Cell Medical Center to explore suitability for their condition.